home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

“Advances in Translational Research and Medicines”

 
  October 19, 2010  
     
 
Zydus Cadila, Zydus Research Centre,Sarkhej-Bavla NH#8A,Moraiya, Ahmedabad-382210
Feb 1-4, 2011


Every two years, Zydus Research Center, the research arm of Zydus Cadila, the fourth largest Indian pharmaceutical company holds an international symposium and attracts active participation from the scientific community worldwide. The focus of this year’s symposium is the use of translational research and medicine to treat cancer, pain, inflamation and cardiometabolic diseases. Our list of invited key speakers include world leading scientists in the cardiometabolic, cancer, inflammation and translational research fraternity both from an academic as well as industry background. I would like to welcome you to visit our symposium website: http://www.rbfsymposium.net/ 

We are currently inviting proposals from leading journals/publishers/newsletters to print the abstracts and proceedings of the event to be held from Feb 1-4, 2011. If you are interested, please respond to us with suitable requirements.

Look forward to welcome you at this symposium. Thanking you in anticipation. Sincerely,Sanjeev Kumar, Ph.D.Promotions, RBF Symposium&Sr. Vice President and Head, BiotechnologyZydus Research CenterAhmedabad, India  
 
 
Organized by: Zydus Cadila
Invited Speakers:

Our list of invited key speakers include world leading scientists in the cardiometabolic, cancer, inflammation and translational research fraternity both from an academic as well as industry background. Some of them are:-

Prof. (Dr.) Rolf Zinkernagel

Nobel Laureate ( Medicine )

University Hospital Zurich,

Switzerland

Dr. Bill Chin

Executive Dean for Research

Harvard Medical School

Former Sr. VP of Discovery &

Clinical Investigation

Eli Lilly & Company, USA

Dr. William Hait

Global therapeutic area head for

oncology R&D, Johnson & Johnson

Pharmaceuticals Group

Dr. Kapil Dhingra

Retired Vice President, Head,

Oncology Disease Biology

Leadership Team, Roche

Dr. John Amatruda

Retired Sr. VP & Franchise Head,

Diabetes/Obesity, Merck, USA

Dr. Nancy Thornberry

Sr. VP, Metabolic Franchise Head,

Merck Research Labs, USA

Dr. Gianni Gromo

Sr. VP and Global Head, Metabolic

& Vascular Disease Area,

Roche, Switzerland

Dr. Richard DiMarchi

Professor & Gill Chair in

Biomolecular Sciences,

Indiana University, USA

Retired Executive VP, Lilly Research

Labs., Indianapolis, USA

And many more.....

 
Deadline for Abstracts: To be decided
 
Registration: http://www.rbfsymposium.net/registration.asp
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.